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Abstract
Highly-reducing polyketide synthases (HR-PKSs) from fungi synthesize complex natural products 
using a single set of domains in a highly programmed, iterative fashion. The most enigmatic 
feature of HR-PKSs is how tailoring domains function selectively during different iterations of 
chain elongation to afford structural diversity. Using the lovastatin nonaketide synthase LovB as a 
model system and a variety of acyl substrates, we characterized the substrate specificity of the 
LovB methyltransferase (MT) domain. We showed that while the MT domain displays 
methylation activity toward different β-ketoacyl groups, it is exceptionally selective towards its 
naturally programmed β-keto-dienyltetraketide substrate with respect to both chain length and 
functionalization. Accompanying characterization of the ketoreductase (KR) domain displays 
broader substrate specificity towards different β-ketoacyl groups. Our studies indicate that 
selective modifications by tailoring domains, such as the MTs, are achieved by higher kinetic 
efficiency on a particular substrate relative to the rate of transformation by other competing 
domains.
Graphical Abstract
Fungal highly-reducing polyketide synthases (HR-PKSs) are multidomain megasynthases 
that are involved in the biosynthesis of diverse polyketide natural products, highlighted by 
the cholesterol lowering agent lovastatin and the protein transport inhibitor brefeldin A.1,2 
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HR-PKSs contain a linearly juxtaposed set of domains that iteratively build the polyketide 
chain through decarboxylative condensation and β-ketoacyl functionalization. In each HR-
PKS, a single set of domains is repeatedly and permutatively used through chain elongation 
cycles to yield the final product. These programmed tailoring steps are precisely executed by 
the HR-PKSs to afford richly functionalized polyketide chains that set up post-PKS 
modifications and afford diverse biological activities. For example, during the synthesis of 
dihydromonacolin L (DML), the precursor to lovastatin, the lovastatin nonaketide synthase 
LovB performs eight cycles of chain extension and tailoring (Figure 1).3,4 The orchestration 
of different tailoring activities sets up key structural features in DML, including the decalin 
core that is proposed to derive from a triene hexaketide intermediate through Diels-Alder 
cyclization;5 and the terminal β-hydroxy acid moiety that is important for inhibition of 
HMG-CoA reductase.6 Compared to bacterial counterparts that function in a well-
understood assembly-line like fashion,7 these complex biochemical features of fungal HR-
PKSs remain unresolved. Knowledge of how tailoring domains function will enable both 
rational manipulation of the megasynthases,8,9 and product prediction from the vast number 
of HR-PKSs uncovered through genome sequencing efforts.
The α-methylation of β-ketoacyl-S-ACP intermediate is a commonly observed modification 
during selected cycles of HR-PKSs.1,10–12 The reaction is catalyzed by an in-line 
methyltransferase (MT) domain using S-adenosylmethionine (SAM) as a cofactor 
immediately following ketosynthase (KS)-catalyzed chain elongation, and occurs prior to β-
reductive modifications performed by ketoreductase (KR), dehydratase (DH) and 
enoylreductase (ER) domains. During the eight chain elongation and tailoring iterations 
catalyzed by LovB, the MT domain is apparently only active during the conversion of 
tetraketide 2-ACP to the on-pathway intermediate 6-ACP, with the α–methyl 3-ACP being 
the product of the MT. Curiously, no methylation modification occurs on other β-ketoacyl-S-
ACP substrates in the other catalytic cycles of LovB (Figure 1). However, α-methylation of 
the tetraketide is essential for the remaining steps of the pathway shown in Figure 1A, as the 
dissociated ER LovC is unable to recognize the α-desmethyl version of 5-ACP and the entire 
catalytic cascade subsequently derails.3,13 The importance of methylation modification on 
the fidelity of other iterative HR-PKSs has also been observed, in which bypassing 
programmed MT function results in production of shunt products.14 _ENREF_19 Therefore, 
the HR-PKSs have clearly evolved to optimize the timing and regioselectivities of the MT 
domains.
We hypothesize that two possible mechanisms of substrate processing can account for LovB 
MT selectivity. First, the HR-PKS may adopt an assembly-line like model in which each 
substrate is passed through the way stations sequentially in the order of MT->KR->DH->ER. 
In the case of LovB, the MT domain only recognizes 2-ACP while excluding all of the other 
substrates completely. Alternatively in a kinetically controlled mechanism, we propose that 
once formed and released from the KS, the β-ketoacyl-S-ACP substrate can sample all 
potential modifying domains, including the MT, KR and KS. The outcome of the tailoring 
steps is determined by the relative activities of each domain towards the substrate. The MT 
domain is primarily in competition with the KR domain for the substrate: if a substrate is 
readily reduced by the KR domain first, then no methyl transfer will be possible. Conversely, 
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a higher MT activity relative to the KR will lead to methylation prior to reduction. To 
understand the basis for the MT selectivity, individual rates of the MT and KR domain 
towards the different β-ketoacyl-S-ACP substrates need to be measured and compared.
We synthesized a panel of acyl-S-N-acetylcysteamine (SNAC) compounds as substrates for 
the MT and KR assays. The majority of the β-ketoacyl-SNAC compounds (Figure 2) were 
prepared using titanium-catalyzed aldol chemistry to synthesize β-hydroxy-carbonyl species 
that were further functionalized and oxidized to provide the desired β-carbonyl SNAC esters 
(Supporting Information).15,16 Access to shorter, saturated SNAC esters was achieved using 
acylated Meldrum’s acid.17,18 The acyl portions of the substrates vary in chain length from 
diketide (C4) to pentaketide (C10) as well as functionalization. Compounds 7, 8 and 2 
represent the natural β-ketoacyl intermediates in the LovB catalytic cycle, while compounds 
9–11 are model, simplified substrates. We also synthesized the corresponding α-methyl-β-
ketoacyl products 12–17 as standards for quantifying the methylation product amount 
(Supporting Information). The synthetic strategy outlined above was expanded to include the 
α-methylated SNAC esters. Rapid ketoenol interconversion excluded the need for 
stereoselective methylation (Supporting information). Furthermore, a number of β-
hydroxylacyl-SNAC compounds were synthesized and used as standards for the 
ketoreduction assay (Supporting Information). These standards were conveniently obtained 
as intermediates in the synthesis of compounds 2, 7–17. Intact LovB was expressed and 
purified from Saccharomyces cerevisiae strain BJ5464-NpgA as previously described and 
used in the assays at final concentrations between 0.01 and 1 μM.4 To allow for 
quantification and prevent further tailoring reactions of the KR products in the assay, we 
constructed a point mutation H985A in the DH domain of LovB to yield LovB-DHo (Figure 
S1).19 LC-MS based product quantification was employed for both the methylation 
(containing SAM) and ketoreduction (containing NADPH) assays, using standard curves 
constructed from the mass signals of synthesized standards.
We first assayed the activity of the MT domain towards the natural tetraketide 2. Overnight 
incubation of 2 mM of 2 in the presence of SAM led to complete consumption of the 
substrate and the appearance of 14. Michaelis-Menten saturation kinetics assay gave a robust 
kcat of 196 min−1 and KM of 170 μM (Figures 2 and S8). The KM value was surprisingly low 
considering acyl-SNAC mimic of the ACP-bound substrates can suffer from significant 
penalties in KM due to loss of protein-protein interactions, and are typically in the millimolar 
range.11,20,21 Hence the kinetic parameters of 2 suggest that the natural tetraketide can bind 
exceptionally well to the active site MT domain of LovB. Having demonstrated the MT 
domain activity can be confirmed with 2, we then tested MT catalysis towards β-ketoacyl-
SNAC substrates of varying chain lengths. No significant (<1%) methylation can be 
observed with either the natural diketide 7 or the model pentaketide substrate 11. The failure 
to methylate 7 is in contrast to that of the chaetoviridin HR-PKS MT domain, which 
naturally methylates β-ketobutyryl-ACP intermediate as well as 7 in the same assay.22 The 
MT domain showed noticeable activity towards converting triketide 8 to 13, albeit 
significantly attenuated compared to that towards 2. Kinetic analysis showed the MT 
displays a 2500-fold drop in catalytic efficiency towards 8 compared to 2, which resulted 
from ~50-fold attenuation in both the kcat and KM values (Figure S10).
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We next assayed the substrate preference of LovB MT towards more simplified substrates 
such as the saturated 10 and 9. While conversion of 10 to 16 was confirmed by using a 
standard of 16, a surprising penalty to the catalytic efficiency (0.3% of 2) was observed 
including a 10-fold decrease in kcat and nearly 40-fold increase in KM (Figure S9). A 7.5-
fold drop in catalytic efficiency compared to 8 was also observed when the γ–δ double bond 
was saturated in the triketide 9 (Figure S11). Collectively, our methylation assays with LovB 
MT domain point to exceptional substrate specificity towards the natural 3-oxo-oct-4,6-
dienyl acyl group. Changes to chain length and functionalization both resulted in significant 
decreases in the methylation rate. The requirement of correct substrate functionalization 
further suggests that the MT domain itself can act as a gatekeeping domain in the 
programming of LovB. In the event that other tailoring domains malfunction in the previous 
cycles and present an alternative substrate, the MT domain activities will be significantly 
attenuated. This would likely result in enzyme stalling or ketoreduction (bypassing the MT 
function) of the substrate, which will eventually result in off-loading of the polyketide 
product as previously demonstrated.4
Having established the substrate scope and kinetic properties of the MT domain, we next 
assayed the properties of the KR domain towards the tri- and tetraketide substrates. Since the 
KR is functional in every iteration of the HR-PKS, we expect the substrate specificities 
towards different β-ketoacyl thioesters to be more relaxed. We used the MS-based 
quantification of substrate conversion, similar to that used in the MT assay. However, 
significant difficulties were encountered when working with the conjugated β-ketoacyl 
substrates such as 2 and 8, due to i) broadening of the peak as a result of enolization of the 
β-keto group; ii) retention time overlap; iii) MS signal overlap due to isotopic abundance of 
the substrate and the actual mass of the product; and iv) spontaneous dehydration of the β-
hydroxyl product (see Figure 3B). Therefore, we used model substrates 9, 15, 10 and 16 to 
perform the kinetics assays. The α-methyl compounds 15 and 16 were chosen to examine 
the effect of methylation of substrate specificity. Following overnight incubation in the 
presence of NADPH and confirmation of product formation using synthesized standards, we 
performed time-course analysis using single substrate concentration of 1 mM and enzyme 
concentration of 5 μM to obtain the apparent turnover rates as shown in Table 1. We also 
attempted to obtain saturation kinetics of the KR domain towards the substrates, however we 
were not able to reach saturation at solubility limits of the substrate with the exception of 9 
which gave kcat of 34.3 min−1 and KM of 2 mM (kcat/KM = 18.5 min−1mM−1) (Figure S12). 
Fitting the linear region of the kinetics data of 10 yielded a kcat/KM value of 5.4 min-1mM-1 
(Figure S13). Although we were not able to obtain full kinetic data on all of the substrates of 
interest, one can still conclude based on Table 1 that the KR domain does not differentiate 
between different substrates significantly (within an order of magnitude). The activity of KR 
is also not significantly affected by the presence of the α-methyl group, suggesting that KR 
does not exert any significant kinetic penalty towards a noncognate substrate. This further 
suggests the importance of substrate specificity at the MT step to determine the first tailoring 
reaction of the β-ketoacyl substrate.
While the acyl-SNAC substrates enabled a relative measure of the domain specificity 
towards different acyl groups, these remain a much-simplified model of the actual ACP-
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bound intermediates that are in cis with all the tailoring domains. To determine if there is 
indeed competitive catalysis between the KR and MT domains towards the β-ketoacyl 
substrates, we performed a combined MT/KR assay in which each substrate (2, 8–10) was 
added to LovB DHo mutant in the presence of both SAM and NADPH, and the amounts of 
each product was compared. The MT-first products can be both the α-methyl-β-keto (+14 
mu) and the α-methyl-β-hydroxyl (+16 mu) compounds, the latter represent the products of 
ketoreduction following methylation. The KR-first products are the β-hydroxyl compounds 
(+2 mu) of which the MT domain can no longer methylate.
We first analyzed the competitive modification of model substrates 9 and 10 since all the 
products can be quantified using standards. As shown in Figure 3A and Figures S14–15, 
when 9 was used in the assay in the presence of equimolar amounts of SAM and NADPH, 
the amount of KR products are significantly more than the MT products (MT/KR product 
ratio of 1:4) when quantified after three hours. This is consistent with the individually 
determined kinetic parameters of which the KR is more active towards triketide 9. Increasing 
the amount of SAM led to higher amount of the MT products. Conversely, using 10 led to 
the reversal of product distribution with MT/KR product ratio of 4:1. This is in spite of the 
kinetic assays showing comparable kcat/KM for both domains towards 10. However, the KM 
of the KR domain towards 10 is very high as we were not able to reach saturation in the 
assay. Hence under assay conditions of 1 mM 10, the binding of the SNAC substrate by the 
KR is likely substantially weaker compared to the MT.
The competition assays were then performed using the natural substrates 2 and 8 and 
analyzed by selected ion monitoring as shown in Figures 3B and 3C. When LovB DHo was 
added to 8 in the presence of both SAM and NADPH, we observed a 10:1 ratio of KR to 
MT-catalyzed products consistent with the natural programming rules of LovB. Most of the 
KR products were found to contain the m/z 215 ion and split into two major peaks. The 
earlier peak at TR~4 min is the β-hydroxyl compound (parent m/z 233 also observed) and 
has undergone dehydration during ionization. A standard of the β-hydroxyl compound gave 
an identical ionization pattern. The second peak at TR~6 min is the actual dehydrated dienyl-
SNAC, which forms readily in aqueous solution. When the natural tetraketide 2 was used in 
the competition assay, only the methylated product 14 was observed. Selected ion 
monitoring revealed that no reduced products can be found in the assay, thereby confirming 
the much higher catalytic efficiency of the MT domain towards 2 compared to that of KR. 
Interestingly, no further β-ketoreduction of 14 can be detected in the assay. Directly using 14 
in a KR-only assay also did not yield any ketoreduced products. This observation is 
unexpected as the acyl portion of 14 is the natural substrate of KR in the predicted 
programmed steps of LovB (Figure 1). Although the exact reason for this result is 
unresolved, one possible explanation may be recognition of the acyl portion of 14 (in the β-
keto form) requires interactions with the ACP as observed in other PKS systems by NMR 
studies.23
Our assays using both natural and model substrates provide an explanation for the 
programmed methylation step observed in the iterative cycles of LovB. We suggest the MT 
and KR domains compete for each of the β-ketoacyl substrates released by the KS domain, 
and the relative rates determine the outcome of the immediate tailoring domain choice. The 
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MT domain of LovB has been precisely tuned to be highly selective for the natural 
tetraketide 2 and to outcompete the KR at this particular step only. Both chain length and 
functional variation in the acyl substrate can lead to substantial penalties in catalytic 
efficiency for the MT domain. In contrast, the KR domain appears to be less substrate 
dependent in terms of catalytic efficiency. As a reflection of the competition between MT 
and KR, a 30-fold drop in the catalytic efficiency of MT towards 10 (as compared to 2) can 
lead to ~20% of the substrate being ketoreduced without being first methylated. As the 
correct methyl substitution is essential for recognition in some (but not all) downstream 
steps,4 this may pose a significant barrier to some precursor-directed biosyntheses of 
polyketides using HR-PKSs. Particular structural variations in precursors can derail the 
programmed steps of the domains and lead to production of shunt products instead. 
However, it is clear from previous work that late steps catalyzed by LovB can proceed 
without methylation to make a des-methyl dihydromonacolin L.4
Our findings with the LovB MT domain poses intriguing questions as to how substrate 
specificity is achieved at the molecular level, how other MT domains in HRPKSs have 
alternative substrate specificities and the possible influence of the HRPKS quaternary 
structure in the intrinsic biosynthetic programming rules of these megasynthases. For 
example, in the fusarielin HRPKS,24 the MT domain is functional on the di-, tri- and 
pentaketide intermediates, while inactive on the tetraketide. This is a complete reversal of 
specificity compared to LovB, and structural comparisons between the two MT domains will 
provide insights into their differences.
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The programed steps of LovB in the synthesis of dihydromonacolin L (DML). (A) The 
catalytic steps by LovB; LovB is a HR-PKS and LovC is the dissociated enoylreductase; and 
(B) the tetraketide modification steps shown in detail highlighting the timing of the MT 
domain. Domain abbreviations: ketosynthase (KS); malonyl-CoA:ACP acyltransferase 
(MAT); α-methyltransferase (MT), β-ketoreductase (KR), dehydratase (DH), α–β 
enoylreductase (ER), acyl carrier protein (ACP) and NRPS-like Condensation (CON).
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Full kinetic analysis of LovB MT domain towards different β-ketoacyl-SNAC substrates. 2 is 
the natural tetraketide substrate based on DML structure. 8 is the on-pathway triketide 
substrate of LovB. No reaction towards diketide 7 or pentaketide 11 was observed.
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KR and MT competition assays using model and natural tri- and tetraketide substrates. (A) 
Quantification of product distribution of model substrates 9 and 10. (B) and (C) Product 
distributions of natural substrates 8 and 2, respectively. Shown are the extract ion 
chromatograms of different products as indicated.
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Table 1
Apparent Turnover rate of LovB KR domain.a
Substrate 9 15 10 16
Turnover (min−1) 16.1±0.5 5.1±0.4 2.1±0.02 2.4±0.1
a
Substrate concentration at 1 mM, enzyme concentration at 5 μM.
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